Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01701674
Brief Title: Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets Pts

First Submitted : October 3, 2012
First Submitted that Met QC Criteria : October 3, 2012
First Posted : October 5, 2012 (Estimate)

Results First Submitted : March 22, 2017
Results First Submitted that Met QC Criteria : March 22, 2017
Results First Posted : May 2, 2017

Last Update Submitted that Met QC Criteria : January 20, 2021
Last Update Posted : February 9, 2021